Please login to the form below

Not currently logged in

Alzheimer's drug treatment

This page shows the latest Alzheimer's drug treatment news and features for those working in and with pharma, biotech and healthcare.

Biogen’s Alzheimers treatment Aduhelm limited to clinical trial participants in the US

Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US

Following a thorough analysis, CMS discovered that although Aduhelm had the potential to help patients with Alzheimer's disease, the drug also had the potential to cause harm. ... Echoing Biogen’s comments, Harry Johns, chief executive officer of the

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation